跳至主要内容
临床试验/NCT02874391
NCT02874391Unknown不适用

Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients

University Hospital, Angers1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Evaluate the risk of complications of AV fistula

研究概览

简要总结

Use of arteriovenous fistula for IV drug administration is controversial and often prohibited by nephrologists. However, we have been using this method in our department for years now in order to keep the patients 'veins for other fistulas in the future. The aim of this study is to evaluate our practice and maybe provide a justification for a larger multi-center study given the importance of this subject in patients with chronic renal failure.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years, functional AV fistula, new kidney transplant recipient

排除标准

  • Prothetic AV fistula, Very recent AV fistula of less than 3 months

结局指标

主要结局

Evaluate the risk of complications of AV fistula

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
University Hospital, Angers
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验